PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Cardiology, National Institute Cardiology Ignacio Chávez, Mexico City, Mexico.\', \'Cardiovascular Post-Surgical Unit, National Institute of Child Health, Lima, Peru.\', \'School of Medicine, Monterrey Institute of Technology and Higher Education. Monterrey, Mexico.\', \'School of Medicine, Cayetano Heredia University, Lima, Peru.\', \'Institute of Cardiology and Cardiovascular Surgery, Juaneda Miramar Hospital, Palma de Mallorca, España.\', \'School of Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.24875/ACM.20000234
?:doi
?:hasPublicationType
?:journal
  • Archivos de cardiologia de Mexico
is ?:pmid of
?:pmid
?:pmid
  • 33459727
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.193
?:rankingScore_hIndex
  • 15
is ?:relation_isRelatedTo_publication of
?:title
  • Adverse effects, pharmacological interactions, and cardiovascular drugs in COVID-19 treatment.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33459727>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33459727>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all